Understanding Semaglutide Semaglutide is an FDA-approved GLP-1 agonist, indicated for the chronic management of weight in adults with obesity, or those overweight with weight-related health conditions
We assess where assumptions are no longer holding across collagen biology, skin barrier function, microbiome dynamics, and demand shifts driven by rapid weight loss and behavioral change
Hormonal therapies are the first choice, before surgery and after surgery, in order to reduce the risk of recurrence
6 real stories
Igarashi, R., Hoshino, J., Ochiai, A., Morizawa, Y
Competing interests The authors declare that there is no conflict of interest in this manuscript